Read Article

Supporting international business matching, LSMIP propritizes "Speed" and "Accuracy" in out service.
Please be noted that contents are in English/Japanese, translated on a request basis from authors/members.
国際間のビジネス・マッチングを促進するため、LSMIPでは情報発信の迅速性・正確性を重視しております。
コンテンツは各言語(英語、日本語)でお読みいただけますが、必要に応じて翻訳する場合があります。

Overview

0

[Yakuji Nippo]Targeting Doubling of Bio-pharmaceutical Market - Specific Strategies for the Next 10 Years

On January 19, 2021, the government presented a draft of the "Bio-Strategy 2020 (Final version of Market Area Measures)" to ...
  • Target market
    Japan
  • Business category
    Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
  • Business function
    Marketing >
  • Keyword
  • Author
    "LSMIP Editorial Office" of "CM Plus Corporation"
  • Availability
    Membership

Detail


株式会社薬事日報社から許諾を受けて、株式会社シーエムプラスが英語に翻訳しております。
オリジナルの正式言語は日本語であり、内容および解釈については日本語が優先されます。
With permission from Yakuji Nippo, Limited, CM Plus Corporation translated into English.
The original article is authored in Japanese, and the Japanese shall prevail in meaning in terms of content and interpretation.

 

Government Strategy Council
Targeting Doubling of Bio-pharmaceutical Market - Specific Strategies for the Next 10 Years

January 22nd, 2021

On January 19, 2021, the government presented a draft of the "Bio-Strategy 2020 (Final version of Market Area Measures)" to the Integrated Innovation Strategy Promotion Council, which summarized the policies that the national government should undertake to strengthen the biotechnology field, and the draft was approved. The government aims to double the domestic market for the industries related to biopharmaceuticals, regenerative medicine, cell therapy, and gene therapy to more than 3.3 trillion yen by 2030 compared to 2020.
 

(Continue to the next)


For this translated article in English, CM Plus Corporation shall have the copyright.
Unauthorized reproduction of posted articles, photos, diagrams, etc. is prohibited.
Copyright © 2021 LSMIP office / CM Plus Singapore Pte. Ltd.

Comments (Require approval)

What information are you looking for in articles?
Let us help you to find out the articles for your business requirements!
Like many other companies, we use cookies and other technologies, some of which are essential to make our website work. By clicking Accept or continuing to use our site, you agree to use these cookies and other technologies. To learn more, check out our privacy policy.
Accept